Zomanex Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Zomanex General Information
Description
Operator of a drug formulation development company intended to transform injectable and oral therapeutics into novel orally delivered medicines. The company's products help in the conversion of injectable xenobiotics into orally deliverable substances, as well as make it easy for hydrophobic compounds to be absorbed in the small intestine, enabling physicians to permit oral dosing of pharmaceutical compounds that have previously been administered intravenously or by injection.
Contact Information
Website
www.zomanex.comCorporate Office
- Suite 2600 Three Bentall Centre
- Post Office Box 49314, 595 Burrard Street
- Vancouver, British Columbia V7X 1L3
- Canada
Corporate Office
- Suite 2600 Three Bentall Centre
- Post Office Box 49314, 595 Burrard Street
- Vancouver, British Columbia V7X 1L3
- Canada
Zomanex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 11-Feb-2025 | Completed | Out of Business | |||
| 1. Later Stage VC (Series A) | 12-Oct-2017 | Completed | Generating Revenue |
Zomanex Patents
Zomanex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2008309010-A1 | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms | Active | 28-Sep-2007 | ||
| AU-2008309010-B2 | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms | Inactive | 28-Sep-2007 | ||
| CA-2701023-A1 | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms | Active | 28-Sep-2007 | ||
| CA-2701023-C | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms | Inactive | 28-Sep-2007 | ||
| EP-2205219-A1 | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms | Active | 28-Sep-2007 | A61K31/337 |
Zomanex FAQs
-
When was Zomanex founded?
Zomanex was founded in 2006.
-
Where is Zomanex headquartered?
Zomanex is headquartered in Vancouver, Canada.
-
What industry is Zomanex in?
Zomanex’s primary industry is Drug Discovery.
-
Is Zomanex a private or public company?
Zomanex is a Private company.
-
What is Zomanex’s current revenue?
The current revenue for Zomanex is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process